CDTI Innovación and European MRR funds support Lifesome Therapeutics’ nanoparticle technology to advance toward clinical trials

by CDTI Innovación

Lifesome Therapeutics is developing an innovative technology based on lipid nanoparticles with intrinsic therapeutic activity for the treatment of cancer. Support from CDTI Innovación and MRR funds h...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Addleshaw Goddard delivers 17% headline ...

by Addleshaw Goddard

Addleshaw Goddard (AG), the London-headquartered international law fir...

Photos Stream